Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial
| Image |  |
|---|---|
| Description | scientific article published on 18 September 2020 |
| Author/s |
author: Georgina V. Long Nageatte Ibrahim James Larkin Paul Lorigan Piotr Rutkowski Paolo Antonio Ascierto Alexander M. M. Eggermont Andrey Meshcheryakov Stefan Suciu Ralf Gutzmer Matteo Carlino Christian U Blank Caroline Robert Jean-Jacques Grob Dirk Schadendorf |
| Publication date | September 18, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |